Yunfei Yuan
- Molecular Biology top 1%
- Cancer Research top 0.2%
- Oncology top 1%
- Hepatology top 0.5%
- Epidemiology top 2%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (69 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers)RNA modifications and cancer (26 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Communications
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Yunfei Yuan
184 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Molecular Biology 4.8k
- Cancer Research 3.7k
- Oncology 1.7k
- Hepatology 1.6k
- Epidemiology 1.1k
Countries citing papers authored by Yunfei Yuan
This map shows the geographic impact of Yunfei Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunfei Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunfei Yuan more than expected).
Fields of papers citing papers by Yunfei Yuan
This network shows the impact of papers produced by Yunfei Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunfei Yuan. The network helps show where Yunfei Yuan may publish in the future.
Co-authorship network of co-authors of Yunfei Yuan
This figure shows the co-authorship network connecting the top 25 collaborators of Yunfei Yuan. A scholar is included among the top collaborators of Yunfei Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunfei Yuan. Yunfei Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 19 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 13 | |
| 8 | TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching studybreakdown → | 71 |
| 9 | 4 | |
| 10 | 10 | |
| 11 | 52 | |
| 12 | Identification of High-Frequency Methylation Sites in RNF180 Promoter Region Affecting Expression and Their Relationship with Prognosis of Gastric Cancer | 1 |
| 13 | 34 | |
| 14 | 42 | |
| 15 | 37 | |
| 16 | 186 | |
| 17 | 88 | |
| 18 | 15 | |
| 19 | 4 | |
| 20 | MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicitybreakdown → | 533 |
About Yunfei Yuan
Yunfei Yuan is a scholar working on Hepatology, Cancer Research and Oncology, having authored 187 papers that have together received 8.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (69 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers) and RNA modifications and cancer (26 papers). The work is most often cited by research in Cancer Research (3.7k citations), Hepatology (1.6k citations) and Molecular Biology (4.8k citations). Yunfei Yuan has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Shi‐Mei Zhuang, Binkui Li, Xin‐Yuan Guan, Jun Huang, Xu Teng, Hang Su, Jian‐Hong Fang, Jiliang Qiu, Jian‐Rong Yang and Leilei Chen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.